Replies to post #197825 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

Wasn't someone wanting to hear this "voluntarily moved into the extension study and was dosed in the extension study for the treatment of Rett syndrome. " the other day.

Also "All eligible patients will be treated with oral liquid ANAVEX®2-73 formulation given once daily for additional 12 weeks. The extension study might be further extended., seems a good message.

[powerwalker]

So, Bio, with my glove in hand and bouncing the ball against the cooler's wall (saw The Great Excape the other night), I'll make my lone post of the day,

Do you believe this person is the first person dosed as mentioned in the March 18th PR, or 14 weeks ago?

As to georgejj's post, "Yes, this is happening in the PDD trial in Spain, at which time their trial period ends, the placebo-burdened participants may join the extension and start to receive the real deal in 2-73."


ANAVEX NOW ... MONO-STYLE ... RWEm for Life!!!

[Jonjones325]

I wonder why we haven’t received the same type of PR for the PDD trial.

[baltimorebullet]

Doesn't the comma after the word patient imply it was the first patient?

BB